Learn how automotive suppliers can prepare for DDRT requests with deeper supply chain visibility, validated data, supporting evidence, and an operational forced labor due diligence process.
4 posts found
A recap of the Supply & Demand Chain Executive webinar featuring Ruben Munoz-Aguilera, Global Risk Manager at Roche Diagnostics, and Kamal Ahluwalia, CEO of Resilinc. When 70% of all medical
At some point, “unprecedented disruption” stops being a useful descriptor. What Resilinc’s 2025 data shows is something more specific: more events, more overlap, and faster downstream impact. Resilinc’s 2025 Annual
Healthcare supply chains face a reality they weren’t originally designed for: disruptions that emerge faster, reach deeper into supplier networks, and directly impact patient care. From ongoing drug shortages to
A look back at the top disruptions to life sciences and healthcare supply chains in Q1 2024, including other key industry news from the quarter. Top disruptions to Healthcare